JP2019214626A5 - - Google Patents

Download PDF

Info

Publication number
JP2019214626A5
JP2019214626A5 JP2019176572A JP2019176572A JP2019214626A5 JP 2019214626 A5 JP2019214626 A5 JP 2019214626A5 JP 2019176572 A JP2019176572 A JP 2019176572A JP 2019176572 A JP2019176572 A JP 2019176572A JP 2019214626 A5 JP2019214626 A5 JP 2019214626A5
Authority
JP
Japan
Prior art keywords
formula
compound
reaction mixture
forming
under conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019176572A
Other languages
English (en)
Japanese (ja)
Other versions
JP7063865B2 (ja
JP2019214626A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019214626A publication Critical patent/JP2019214626A/ja
Publication of JP2019214626A5 publication Critical patent/JP2019214626A5/ja
Priority to JP2022016438A priority Critical patent/JP7333843B2/ja
Application granted granted Critical
Publication of JP7063865B2 publication Critical patent/JP7063865B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019176572A 2014-09-16 2019-09-27 Toll様受容体モジュレーターを調製する方法 Active JP7063865B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022016438A JP7333843B2 (ja) 2014-09-16 2022-02-04 Toll様受容体モジュレーターを調製する方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462051044P 2014-09-16 2014-09-16
US62/051,044 2014-09-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018134200A Division JP6596127B2 (ja) 2014-09-16 2018-07-17 Toll様受容体モジュレーターを調製する方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022016438A Division JP7333843B2 (ja) 2014-09-16 2022-02-04 Toll様受容体モジュレーターを調製する方法

Publications (3)

Publication Number Publication Date
JP2019214626A JP2019214626A (ja) 2019-12-19
JP2019214626A5 true JP2019214626A5 (enExample) 2020-02-06
JP7063865B2 JP7063865B2 (ja) 2022-05-09

Family

ID=54291584

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017514494A Active JP6373490B2 (ja) 2014-09-16 2015-09-14 Toll様受容体モジュレーターを調製する方法
JP2018134200A Active JP6596127B2 (ja) 2014-09-16 2018-07-17 Toll様受容体モジュレーターを調製する方法
JP2019176572A Active JP7063865B2 (ja) 2014-09-16 2019-09-27 Toll様受容体モジュレーターを調製する方法
JP2022016438A Active JP7333843B2 (ja) 2014-09-16 2022-02-04 Toll様受容体モジュレーターを調製する方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2017514494A Active JP6373490B2 (ja) 2014-09-16 2015-09-14 Toll様受容体モジュレーターを調製する方法
JP2018134200A Active JP6596127B2 (ja) 2014-09-16 2018-07-17 Toll様受容体モジュレーターを調製する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022016438A Active JP7333843B2 (ja) 2014-09-16 2022-02-04 Toll様受容体モジュレーターを調製する方法

Country Status (20)

Country Link
US (1) US9573952B2 (enExample)
EP (3) EP3848375B1 (enExample)
JP (4) JP6373490B2 (enExample)
KR (3) KR102457426B1 (enExample)
CN (2) CN107074860B (enExample)
AR (1) AR101882A1 (enExample)
AU (2) AU2015318062B2 (enExample)
BR (1) BR112017005100A2 (enExample)
CA (1) CA2960384C (enExample)
EA (1) EA201790373A1 (enExample)
ES (3) ES2706527T3 (enExample)
IL (1) IL250849A0 (enExample)
MX (1) MX2017003288A (enExample)
NZ (1) NZ729526A (enExample)
PL (2) PL3461828T3 (enExample)
PT (2) PT3461828T (enExample)
SG (1) SG11201701472VA (enExample)
SI (1) SI3461828T1 (enExample)
TW (2) TWI692468B (enExample)
WO (1) WO2016044183A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA026557B1 (ru) 2008-12-09 2017-04-28 Джилид Сайэнс, Инк. Промежуточные соединения для получения модуляторов толл-подобных рецепторов
PT3166607T (pt) 2014-07-11 2022-12-07 Gilead Sciences Inc Moduladores de receptores de tipo toll para o tratamento do vih
AU2015318061B2 (en) 2014-09-16 2018-05-17 Gilead Sciences, Inc. Solid forms of a toll-like receptor modulator
CN111065636B (zh) * 2017-09-22 2022-08-23 江苏恒瑞医药股份有限公司 稠合杂芳基衍生物、其制备方法及其在医药上的应用
US20250346931A1 (en) * 2022-04-26 2025-11-13 Bigelow Laboratory For Ocean Sciences Methods for producing halogenated compounds

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
HU212924B (en) 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
JP2886570B2 (ja) 1989-09-29 1999-04-26 エーザイ株式会社 縮合ヘテロ環を有する化合物
JPH05320143A (ja) * 1992-03-18 1993-12-03 Mochida Pharmaceut Co Ltd 新規ピリミジン誘導体
TW274550B (enExample) 1992-09-26 1996-04-21 Hoechst Ag
IL112235A (en) 1994-01-03 2000-06-29 Acea Pharm Inc 1,4-dihydro-pyrido¬2,3-b¾pyrazine-2,3-dione (5 or 8) oxide derivatives and pharmaceutical compositions containing them
ZA973884B (en) 1996-05-23 1998-11-06 Du Pont Merck Pharma Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
EA003188B1 (ru) 1996-08-06 2003-02-27 Пфайзер Инк Замещенные пиридо- или пиримидосодержащие 6,6- или 6,7-бициклические производные
US5693641A (en) 1996-08-16 1997-12-02 Berlex Laboratories Inc. Bicyclic pyrimidine derivatives and their use as anti-coagulants
AU4719699A (en) 1998-06-26 2000-01-17 Du Pont Pharmaceuticals Company Substituted quinoxalin-2(1h)-ones useful as hiv reverse transcriptase inhibitors
WO2001019825A1 (en) 1999-09-15 2001-03-22 Warner-Lambert Company Pteridinones as kinase inhibitors
US6452325B1 (en) 2000-07-24 2002-09-17 Thermoplastic Processes, Inc. Shatterproofing of fluorescent lamps
WO2002076954A1 (en) 2001-03-23 2002-10-03 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
US6806272B2 (en) 2001-09-04 2004-10-19 Boehringer Ingelheim Pharma Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
NZ531928A (en) 2001-09-04 2005-10-28 Boehringer Ingelheim Pharma Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
MXPA05009068A (es) 2003-02-26 2005-10-19 Boehringer Ingelheim Pharma Dihidro-pteridinonas, metodo para la produccion y uso del mismo en la forma de farmacos.
EP2269638A3 (en) 2004-05-28 2012-06-13 GlaxoSmithKline Biologicals S.A. Vaccine compositions comprising virosomes and a saponin adjuvant
DE102004029784A1 (de) 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
BRPI0611435A2 (pt) 2005-05-04 2010-09-08 Pfizer Ltd derivados de 2-amido-6-amino-8-oxopurina, composições farmacêuticas, uso e processo de preparo dos mesmos
EP1915155A1 (en) 2005-08-03 2008-04-30 Boehringer Ingelheim International GmbH Dihydropteridinones in the treatment of respiratory diseases
WO2007034917A1 (ja) 2005-09-22 2007-03-29 Dainippon Sumitomo Pharma Co., Ltd. 新規なアデニン化合物
EP2657235A1 (en) * 2005-10-28 2013-10-30 Ono Pharmaceutical Co., Ltd. Compound containing basic group and use thereof
CA2644850A1 (en) * 2006-03-08 2007-09-13 Amgen Inc. Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
EP2004193A2 (en) 2006-03-13 2008-12-24 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
EP2035422A1 (en) 2006-06-23 2009-03-18 AstraZeneca AB Pteridine derivatives and their use as cathespin inhibitors
MX2009004077A (es) 2006-10-19 2009-05-05 Signal Pharm Llc Compuestos de heteroarilo, composiciones de los mismos, y su uso como inhibidores de proteina cinasas.
PT2125792E (pt) 2007-02-19 2011-03-01 Glaxosmithkline Llc Derivados de purina como imunomoduladores
PT2139892E (pt) 2007-03-22 2011-11-21 Takeda Pharmaceutical Pirimidodiazepinas substituídas úteis como inibidores da plk1
KR20120003499A (ko) * 2007-04-05 2012-01-10 지멘스 메디컬 솔루션즈 유에스에이, 인크. 클릭 화학을 이용한 탄산탈수효소―ⅰⅹ에 대한 분자 영상화 프로브의 제조
US20100179109A1 (en) * 2007-04-05 2010-07-15 Baldwin Jonh J Renin inhibitors
KR101524817B1 (ko) * 2007-04-18 2015-06-01 깃세이 야쿠힌 고교 가부시키가이샤 질소 함유 축합환 유도체, 그것을 함유하는 의약 조성물 및 그 의약 용도
EP2190849B1 (en) 2007-08-15 2013-11-20 Vertex Pharmceuticals Incorporated 4-(9-(3,3-difluorocyclopentyl)-5,7,7-trimethyl-6-oxo-6,7,8,9-tetrahydro-5h-pyrimido[4,5-b[1,4]diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases
WO2009022185A2 (en) 2007-08-16 2009-02-19 Astrazeneca Ab 6, 6-fused heterocycles, their pharmaceutical compositions and methos of use
US20090291938A1 (en) 2007-11-19 2009-11-26 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
CN101284810A (zh) * 2008-06-02 2008-10-15 秦引林 氰基吡咯烷和氰基噻唑烷衍生物
EA026557B1 (ru) 2008-12-09 2017-04-28 Джилид Сайэнс, Инк. Промежуточные соединения для получения модуляторов толл-подобных рецепторов
CA2772253C (en) * 2009-09-14 2018-02-27 Gilead Sciences, Inc. Modulators of toll-like receptors
TW201306841A (zh) 2010-12-20 2013-02-16 Gilead Sciences Inc 治療c型肝炎病毒(hcv)之方法

Similar Documents

Publication Publication Date Title
JP2019214626A5 (enExample)
JP2019516692A5 (enExample)
JP3989377B2 (ja) プロスタグランジン誘導体の製造方法及びその立体特異的出発物質
JP2022043078A5 (enExample)
JP5048408B2 (ja) 臭化チオトロピウムの調製方法
RU2009110413A (ru) Способ получения производных 3-дигалогенметил-пиразол-4-карбоновой кислоты
JP2010535206A5 (enExample)
JP2005501841A5 (enExample)
JP2010532365A5 (enExample)
JP2013520495A5 (enExample)
JP2009544591A (ja) 臭化3(r)−(2−ヒドロキシ−2,2−ジチエン−2−イルアセトキシ)−1−(3−フェノキシプロピル)−1−アゾニアビシクロ[2.2.2]オクタンの製造方法
JP2007077384A5 (enExample)
JP2016511269A (ja) (2s,5r)−6−ベンジルオキシ−7−オキソ−1,6−ジアザ−ビシクロ[3.2.1]オクタン−2−カルボン酸のナトリウム塩およびその調製
JP2019524752A5 (enExample)
JP2022116171A5 (enExample)
JP2007530602A5 (enExample)
JP2005502603A5 (enExample)
JP2006518765A5 (enExample)
JPS6140234B2 (enExample)
JP4681617B2 (ja) ヒンバシンアナログの合成
JP2018506541A5 (enExample)
JP4580758B2 (ja) プロスタグランジン誘導体の製造方法及びその出発物質
JP2006528215A5 (enExample)
JP2011502147A5 (enExample)
JP2004269891A5 (enExample)